title: Differential diagnosis between organic and inorganic mercury poisoning in human cases--the pathologic point of view.
abstract: Differences in pathology were found between acute and chronic exposure to methylmercury, mercury vapor, and inorganic mercury. Characteristic pathologic changes produced by organic mercury in the brain have previously been described in patients with Minamata disease. The brains of patients who presented with acute onset of symptoms and died within 2-mo showed loss of neurons with reactive proliferation of glial cells, microcavitation, vascular congestion, petechial hemorrhage, and edema in the cerebral cortices, predominantly in the calcarine, pre- and postcentral, and transverse temporal cortices and in the cerebellar cortex. The neuropathologic changes in the patients with acute onset of symptoms who survived for a long period (>10 yr) were also included neuronal loss with reactive proliferation of glial cells in similar anatomic locations. The neuropathologic changes in patients with inorganic mercury poisoning are quite different. Autopsies performed on 3 individuals with fatal cases of acute inorganic mercury poisoning who were exposed to mercury vapor for about 2 wk revealed diffuse organized pneumonia, renal cortical necrosis, disseminated intravascular coagulopathy, and infarctions in the brain and kidneys. In 2 other patients who worked in mercury mines for about 10 yr and who suffered from chronic inorganic poisoning, no specific lesions were demonstrated in the brain. However, the assay and the histochemistry of mercury revealed that inorganic mercury was present in the brain in all 3 groups irrespective of the brain lesions and the duration of clinical signs.
authors.affiliation: National Institute for Minamata Disease, Environment Agency, Minamata City, Kumamoto, Japan. kometo@nimd.go.jp
authors.forename: K
authors.initials: K
authors.lastname: Eto
authors.forename: Y
authors.initials: Y
authors.lastname: Takizawa
authors.forename: H
authors.initials: H
authors.lastname: Akagi
authors.forename: K
authors.initials: K
authors.lastname: Haraguchi
authors.forename: S
authors.initials: S
authors.lastname: Asano
authors.forename: N
authors.initials: N
authors.lastname: Takahata
authors.forename: H
authors.initials: H
authors.lastname: Tokunaga
mesh_terms: D000328:Adult; D000368:Aged; D001921:Brain / Q000378:metabolism* / Q000473:pathology*; D003937:Diagnosis, Differential; D005260:Female; D005911:Gliosis / Q000139:chemically induced / Q000473:pathology; D006651:Histocytochemistry; D006801:Humans; D008297:Male; D008628:Mercury / Q000378:metabolism; D020262:Mercury Poisoning, Nervous System / Q000378:metabolism / Q000473:pathology*; D008767:Methylmercury Compounds / Q000378:metabolism; D008875:Middle Aged; D009474:Neurons / Q000187:drug effects / Q000473:pathology; D017933:Peripheral Nervous System / Q000378:metabolism / Q000473:pathology; D012016:Reference Values; D013116:Spinal Cord / Q000378:metabolism / Q000473:pathology; D014018:Tissue Distribution
chemical_list: D008767:Methylmercury Compounds; D008628:Mercury